
Brief: The Promises & (Mostly) Perils of Ketamine Therapy
Conspirituality
00:00
The Future of Ketamine
In March 2019, the FDA approved the usage of ketamine under the trade name Sbravado for clinical use in treatment resistant depression therapy. Ketamine is not a psychedelic, but rather a hallucinogen and a disassociative. It has been used broadly as a sedative and anesthetic to aid in emergency surgeries in war zones.
Transcript
Play full episode